171 related articles for article (PubMed ID: 11061854)
1. Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion-transmitted HCV infection.
Legler TJ; Riggert J; Simson G; Wolf C; Humpe A; Munzel U; Uy A; Köhler M; Heermann KH
Transfusion; 2000 Oct; 40(10):1192-7. PubMed ID: 11061854
[TBL] [Abstract][Full Text] [Related]
2. HCV screening in blood donations using RT-PCR in mini-pool: the experience in Spain after routine use for 2 years.
Eiras A; Sauleda S; Planelles D; Sedeño M; Ibarra A; Vesga MA; Franco E; Montoro JA; Hernández JM; Villaescusa RG
Transfusion; 2003 Jun; 43(6):713-20. PubMed ID: 12757521
[TBL] [Abstract][Full Text] [Related]
3. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.
Weusten JJ; van Drimmelen HA; Lelie PN
Transfusion; 2002 May; 42(5):537-48. PubMed ID: 12084161
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.
Hyland C; Seed CR; Kiely P; Parker S; Cowley N; Bolton W
Vox Sang; 2003 Jul; 85(1):1-8. PubMed ID: 12823724
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
Fang CT; Field SP; Busch MP; Heyns Adu P
Vox Sang; 2003 Jul; 85(1):9-19. PubMed ID: 12823725
[TBL] [Abstract][Full Text] [Related]
6. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
[TBL] [Abstract][Full Text] [Related]
7. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
Bruhn R; Lelie N; Busch M; Kleinman S;
Transfusion; 2015 Jun; 55(6):1195-205. PubMed ID: 25727549
[TBL] [Abstract][Full Text] [Related]
8. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
Galel SA; Strong DM; Tegtmeier GE; Holland PV; Kuramoto IK; Kemper M; Pietrelli L; Gallarda J
Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226
[TBL] [Abstract][Full Text] [Related]
9. Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe.
Roth WK; Weber M; Buhr S; Drosten C; Weichert W; Sireis W; Hedges D; Seifried E
Transfusion; 2002 Jul; 42(7):862-8. PubMed ID: 12375658
[TBL] [Abstract][Full Text] [Related]
10. Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.
Jongerius JM; Sjerps M; Cuijpers HT; van Drimmelen HA; van der Poel CL; Reesink HW; Molijn MH; Peeters GA; Peeters TP; Lelie PN
Transfusion; 2002 Jun; 42(6):792-7. PubMed ID: 12147034
[TBL] [Abstract][Full Text] [Related]
11. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
12. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
13. Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV.
Hitzler WE; Runkel S
Transfusion; 2001 Mar; 41(3):333-7. PubMed ID: 11274586
[TBL] [Abstract][Full Text] [Related]
14. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.
Koppelman MH; Assal A; Chudy M; Torres P; de Villaescusa RG; Reesink HW; Lelie PN; Cuypers HT
Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910
[TBL] [Abstract][Full Text] [Related]
15. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
[TBL] [Abstract][Full Text] [Related]
16. Primary screening of blood donors by nat testing for HCV-RNA: development of an "in-house" method and results.
Wendel S; Levi JE; Takaoka DT; Silva IC; Castro JP; Torezan-Filho MA; Ghaname J; Gioachini R; Brandão J; Durigon EL
Rev Inst Med Trop Sao Paulo; 2007; 49(3):177-85. PubMed ID: 17625696
[TBL] [Abstract][Full Text] [Related]
17. Automated screening of blood donations for hepatitis C virus RNA using the Qiagen BioRobot 9604 and the Roche COBAS HCV Amplicor assay.
Grant PR; Sims CM; Krieg-Schneider F; Love EM; Eglin R; Tedder RS
Vox Sang; 2002 May; 82(4):169-76. PubMed ID: 12047510
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system.
Candotti D; Richetin A; Cant B; Temple J; Sims C; Reeves I; Barbara JA; Allain JP
Transfusion; 2003 Feb; 43(2):215-25. PubMed ID: 12559017
[TBL] [Abstract][Full Text] [Related]
19. Incidence of hepatitis C virus RNA in anti-HCV negative plasma pools in Croatia.
Forcić D; Zgorelec R; Branović K; Kosutić-Gulija T; Santak M; Mazuran R
Transfus Apher Sci; 2001 Jun; 24(3):269-78. PubMed ID: 11791702
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of automated nucleic acid extraction devices for application in HCV NAT.
Jongerius JM; Bovenhorst M; van der Poel CL; van Hilten JA; Kroes AC; van der Does JA; van Leeuwen EF; Schuurman R
Transfusion; 2000 Jul; 40(7):871-4. PubMed ID: 10924618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
